RHI · Robert Half Inc. · Stock research

Current Thesis

The July framing of this name — secular white-collar staffing decline, a >5% yield reading as a value trap — has been overrun by the tape. The adjusted close on 2026-08-14 was $43.22, 1.3% under the 52-week high of $43.78, after a 75.9% three-month advance. The narrative leg being bought is specific and dated: BMO Capital upgraded to Outperform on 2026-07-27 (target $45 → $47) on the call that Q2 2026 marked the low of the business cycle, with revenue growth and margin expansion from Q3 onward; That is an early-cycle labor-recovery trade wearing a legacy staffing name. The unresolved part: the 18-analyst average target of $30.27 sits far below spot, and no company datapoint tests the trough call until the Q3 print, scheduled around 2026-10-21.

Bullish and bearish views on Robert Half Inc.

The model's bull view on Robert Half Inc. (RHI), in brief: BMO upgrade 2026-07-27, Market Perform → Outperform, PT $45 → $47, explicitly naming Q2 2026 the cyclical low with revenue growth and improving margins from Q3. The bear view: Price already trades well above the analyst centre of gravity: $43.22 on 2026-08-14 versus an $30.27 average across 18 analysts. Both cases follow in full.

Bull Case

• BMO upgrade 2026-07-27, Market Perform → Outperform, PT $45 → $47, explicitly naming Q2 2026 the cyclical low with revenue growth and improving margins from Q3.
• Robert Half survey released 2026-07-29: 66% of more than 2,000 US hiring managers plan to increase permanent hiring in H2 2026 (60% in H1 2026, 57% a year earlier) — the sequential direction is what perm-placement fees key on.
• Q2 2026 (2026-07-23): revenue $1.336B beat the $1.322B consensus, the first top-line beat after multiple quarters of decline; EPS $0.26 inline.
• Q3 2026 guidance of EPS $0.43–$0.53 embeds a step-up off the $0.26 Q2 trough; sales guided $1.310B–$1.410B.
• Board declared a $0.59 quarterly dividend on 2026-08-03, payable 2026-09-15 — the payout was maintained through the earnings trough, which removes the near-term dividend-cut leg of the value-trap case.
• The sell-side sits below the market: with the 18-analyst average at $30.27 and a 6-analyst consensus near $32, only Truist ($50, 2026-07-22) and BMO ($47, 2026-07-27) are above the 2026-08-14 close. If Q3 confirms the trough, target revisions become a mechanical source of headlines (inference, not measured).

Bear Case

• Price already trades well above the analyst centre of gravity: $43.22 on 2026-08-14 versus an $30.27 average across 18 analysts. The re-rate has been multiple, not delivered earnings.
• Kevin McVeigh reiterated Sell with a $20 target in early-August coverage, citing weak hiring and softening Protiviti trends — the consulting arm that was supposed to be the counter-cyclical offset.
• The declared $0.59 quarterly dividend (2026-08-03) exceeds Q2 2026 EPS of $0.26. At trough earnings the payout is being funded from the balance sheet.
• The Q3 sales guide spans $1.310B–$1.410B, a $100M range. The current price effectively requires the upper half of that band.
• The entire leg rests on a survey of hiring intentions (2026-07-29) and one broker's cycle call (2026-07-27). Neither is booked revenue.
• Protiviti leadership changes on 2026-08-03: Cory Gunderson becomes president and CEO effective 2027-01-01, with Joe Tarantino moving to senior managing director — execution change at the higher-margin segment while it is under scrutiny.
• The AI-automation argument against permanent placement in finance, accounting and admin roles has not been retired by anything reported since 2026-07-23; it has only been out-shouted by the cycle call.

Setup & Price Structure

• The narrative is accelerating. What dates it — the 2026-07-27 upgrade, the 2026-07-29 hiring survey, and a 5.4% single-day gain on 2026-08-13 to a fresh 52-week high at $43.78. New attention arriving at new highs, not fading flow.
• The 2026-07-24 post-earnings selloff has been fully reclaimed and exceeded; a breakdown that reverses into a 52-week high is the shape that turned the prior bearish structural read.
• RSI(14) at 62.3 on 2026-08-14 with a 75.9% three-month gain: the advance has been persistent rather than vertical, and the momentum reading is not yet at an extreme.
• Crowding observables, stated as observables: income screens featured RHI repeatedly before the run (Benzinga high-dividend-yield industrials pieces on 2026-06-30 and 2026-07-15); a screen-site note published on the up-5.4% day itself (2026-08-13) carried a momentum rank of 10/10 and a "still undervalued" fair-value frame of $55.76 — coverage arriving at the high.
• Positioning gap: the marginal buyer is paying above nearly the whole published target band. Trend and yield demand, not target-driven institutional demand, is what is setting the price here (inference).
• No insider transactions surfaced in the recent-filings feed reviewed through 2026-08-14.
• No company-specific event inside 30 days. The nearest hard resolution is the Q3 print around 2026-10-21 — the trend must hold on macro prints alone until then.
• Note on series: a screen-site 52-week range of $21.83–$44.18 (2026-08-13) uses intraday values and differs from the split/dividend-adjusted close series referenced above, where the 52-week high is $43.78.

Catalyst Calendar (next 30 days)

• ~2026-09-02 (est.): JOLTS job-openings release for July — openings and quits are the leading input to contract-talent demand.
• ~2026-09-04 (est.): BLS employment situation report for August — professional and business services payrolls are the direct read-through to placement volumes.
• 2026-09-15: $0.59 quarterly dividend payable (declared 2026-08-03) — cash confirmation of the payout through the trough.
• ~2026-09-16 (est.): FOMC decision — easing expectations are the discount-rate input behind the early-cycle staffing bid.
• ~2026-10-21 (est.): Q3 2026 results — outside the 30-day window, and the first hard test of the $0.43–$0.53 EPS guide and of BMO's trough call.

What Would Change Our Mind

The structure that has to hold is the August advance to new highs; the fundamental claim that has to hold is that Q2 2026 was the earnings low. A weekly close below $38 would end the trend leg — roughly 12% under the 2026-08-14 close of $43.22, enough of a give-back to unwind the August breakout without waiting for October. Secondary conditions, each observable: permanent-placement revenue still down year-over-year at the Q3 print around 2026-10-21 even as contract talent recovers, which would restore the secular read over the cyclical one; a Q3 result at or below the guide midpoint with no FY revision; Protiviti revenue declining sequentially, validating McVeigh's early-August objection; or the August payrolls print around 2026-09-04 showing professional and business services employment falling, which would make the 66% hiring-intentions survey an intentions-only datapoint. On the other side, the theme would flip to saturated if the sell-side target band closes the gap to spot and price stops making new highs on the upgrades.

Correlation Notes

• Moves with the labor cycle complex: ManpowerGroup and RHI both appeared in the same "moving higher" group on 2026-07-16, and staffing names trade as one basket on payroll and JOLTS prints.
• Rate-path sensitive: early-cycle staffing has historically re-rated ahead of confirmed hiring data on easing expectations, which ties the name to the ~2026-09-16 FOMC.
• Protiviti attaches a consulting-cycle correlation that the pure staffing peers do not carry — enterprise risk/internal-audit budgets rather than placement volumes.
• The AI capex narrative that lifts semiconductors is cited as the structural bear case for white-collar placement volumes, so RHI can trade inversely to the dominant market narrative on days when AI-labor-displacement headlines dominate.